FURUTA MILANO (Chief Financial Officer) received a stock award from TAKEDA PHARMACEUTICAL CO LTD
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/6/2026ACC: 0001395064-26-000260
DirectorOfficer· Chief Financial Officer
Since Mar 2026
+8.54K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
25.16K acquired · 16.62K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+12.30K
Price / share
—
Trade value
—
% of position
21.2%
7/1/2026
57.90K→70.20K
Total
Net shares
+12.30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 7/1/2026 | A · Award | +12.30K | — | — | 21.2% | 57.90K | 70.20K |
| Total | +12.30K | $0.00 | ||||||
Derivative Transactions4
Tax Obligation Award
Direct
Converts to
Ordinary Shares
4.29K shares
Shares
+4.29K
Strike price
Held after
11.74K
Exercisable
—
7/1/2026
Tax Obligation Award
Direct
Converts to
Ordinary Shares
4.29K shares
Shares
+4.29K
Strike price
Held after
8.48K
Exercisable
—
7/1/2026
Tax Obligation Award
Direct
Converts to
Ordinary Shares
4.29K shares
Shares
+4.29K
Strike price
Held after
4.29K
Exercisable
—
7/1/2026
Tax Obligation Award
Direct
Converts to
Ordinary Shares
16.62K shares
Shares
−16.62K
Strike price
Held after
0.00
Exercisable
—
7/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Tax Obligation Award Direct | Ordinary Shares4.29K shares | 7/1/2026 | A · Award | +4.29K | — | 11.74K | |
| Tax Obligation Award Direct | Ordinary Shares4.29K shares | 7/1/2026 | A · Award | +4.29K | — | 8.48K | |
| Tax Obligation Award Direct | Ordinary Shares4.29K shares | 7/1/2026 | A · Award | +4.29K | — | 4.29K | |
| Tax Obligation Award Direct | Ordinary Shares16.62K shares | 7/10/2026 | D · Disposition | −16.62K | — | 0.00 |